Back to Results
First PageMeta Content
Science / Health / Clinical trials / Food and Drug Administration / Medical statistics / Investigational New Drug / Investigational Device Exemption / Neurofibromatosis / Patient recruitment / Research / Clinical research / Pharmaceutical industry


Program Announcement Department of Defense Congressionally Directed Medical Research Programs Neurofibromatosis Research Program Clinical Trial Award Funding Opportunity Number: W81XWH-09-NFRP-CTA TABLE OF CONTENTS
Add to Reading List

Document Date: 2009-01-21 08:49:43

Open Document

File Size: 136,27 KB

Share Result on Facebook

Company

Facilities & Other Resources / NFRP Research Resources / /

Currency

USD / /

/

Event

FDA Phase / Person Communication and Meetings / /

IndustryTerm

clinical protocol / study site / potential clinical applications / duplicative applications / • Equipment / /

MedicalCondition

specified disease / neoplasms / disease / neurofibromatosis / pain / /

MedicalTreatment

CLINICAL PROTOCOL / /

NaturalFeature

Summer/Early Fall / /

Organization

USAMRMC office of Research Protections / Program Announcement Department / Institutional Review Board / United States Army / E. Award Administration / Human Research Protection Office / Commanding General / US Army Medical Research and Materiel Command / Department of Defense / office of the Congressionally Directed Medical Research Programs / Human Subjects Research Review Board / /

/

Position

investigator / Governor / Grants Officer / Principal Investigator / coordinator / study coordinator / Representative / General / R.N. / /

Product

Bang & Olufsen Form 2 Headphone/Headset / Intervention / Investigational New Drug / /

ProvinceOrState

Newfoundland / /

PublishedMedium

Peer Review / R&R / /

Technology

regulatory issues Protocol / clinical protocol / 8 CLINICAL PROTOCOL / /

URL

http /

SocialTag